About this site
Ibogaine.info was created as a public resource -- an attempt to build the clearest, most honest, and most fully referenced overview of ibogaine available on the open internet. It is written for people considering treatment, for journalists and policymakers who need reliable information, and for anyone curious about a substance that sits at a genuinely significant moment in medicine and public policy.
The site is independent. It has no financial relationship with any treatment clinic, pharmaceutical company, research institution, or advocacy organisation. It does not accept advertising. It does not receive payments for referrals. It does not promote any specific provider, product, or political position on ibogaine.
The editorial standard is simple: every substantive claim should be traceable to a primary source. Where evidence is limited or contested, the site says so. Where risks are serious, the site leads with them. Where something is unknown, the site says it is unknown.
Our principles
Independence
This site has no commercial relationships. No clinic, company, or organisation has paid for, influenced, or reviewed any content before publication. Editorial decisions are made solely by the site's creator.
Transparency about evidence
We distinguish between strong evidence and weak evidence, between randomised controlled trials and anecdotal reports, and between what is known and what is not yet known. We do not overstate the science in either direction.
Safety first
Risks are never buried or minimised. The cardiac risks associated with ibogaine are presented clearly on every relevant page. We believe that honest safety information protects people; obscuring it does not.
Respect for indigenous knowledge
The Bwiti tradition predates Western medicine's engagement with ibogaine by centuries. This site acknowledges that the therapeutic insights now being explored in clinical trials owe a debt to indigenous practitioners and cultural custodians of the iboga plant.
Active maintenance
The ibogaine field is moving quickly. Policy, research, and legal status are all changing. This site is actively maintained and updated as significant developments occur. Each page carries the month it was last reviewed.
How this site is written and checked
Ibogaine.info is edited by a psychologist (Utrecht University) with more than 25 years of experience supporting people before and after psychedelic experiences. The editor works independently in that field; this site does not promote, link to or refer readers to that work, and it has no financial relationship with any ibogaine provider.
Before a page is published or updated, three checks are made.
- References are verified against the original record. Each study is checked via its DOI, PubMed entry or the publisher's page, so that authors, title, journal and year match the source. A link that merely loads is not enough: it has to lead to the study that is cited.
- Legal status is checked against official sources. Where a regulator or government publishes the rule, that document is the source, not a secondary summary.
- Every page carries its review date. The month shown at the top of each page is when its content was last checked. Pages on legal status and recent developments are reviewed whenever significant changes occur.
Corrections
Mistakes are corrected openly. Significant corrections are listed here.
- October 2026. Canada was described as a country where ibogaine is legal and clinics operate openly. It has been prescription-only since 2017 and its open clinics have largely closed. Germany was described as controlling ibogaine under its narcotics law; it is not listed there. Australia and South Africa have been updated to prescription-only. The US timeline now gives 1970 as the year of scheduling and describes the end of NIDA's programme in 1995 more accurately. The safety page now explains the QT interval correctly and states that continuous ECG monitoring, not a pulse oximeter, is required.
- May 2026. A full check of every reference found seven entries with errors, including incorrect DOIs, wrong author lists and one DOI that led to an unrelated study. All seven were corrected, and placeholder links throughout the site were completed.
Legal disclaimer
Please read carefully
This site does not provide medical advice. The information on ibogaine.info is provided for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Always consult a qualified physician before considering any treatment involving ibogaine or any other psychoactive substance. Never disregard professional medical advice or delay seeking it because of something you have read on this site.
This site does not recommend specific treatment providers. The mention of treatment clinics or provider locations is for informational purposes only and does not constitute an endorsement, recommendation, or quality assessment of any particular provider.
Legal status varies by jurisdiction. Information about the legal status of ibogaine is provided as general reference and may not reflect the most current law in your location. It does not constitute legal advice. Consult a qualified legal professional in your jurisdiction before making any decisions based on legal status information.
The site accepts no liability for any harm, loss, or damage arising from reliance on information contained on ibogaine.info. All use of this site is at the user's own risk.
Copyright & use of content
The original content on ibogaine.info -- including written text, page structure, and design -- is the copyright of the site's creator. You are welcome to quote from the site with attribution and a link to the original page.
Journalists, researchers, and educators are welcome to reproduce limited excerpts for non-commercial purposes with attribution. For any other use, please make contact via the email address below.
Scientific references cited on this site belong to their respective authors and publishers. Links to primary sources are provided wherever possible; please follow those links and cite the original research rather than this site when referencing academic content.
Contact
For corrections, questions, suggestions for content, or any other correspondence, please write to: info@ibogaine.info
We welcome corrections. If you believe any content on this site is factually inaccurate, please write with the specific claim, the page it appears on, and the source you believe contradicts it. We will review and respond.